𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II Trial of Liposomal Doxorubicin (Doxil®) in Advanced Soft Tissue Sarcomas

✍ Scribed by T. Chidiac; G.T. Budd; R. Pelley; K. Sandstrom; D. McLain; P. Elson; R. Crownover; K. Marks; G. Muschler; M. Joyce; R. Zehr; R. Bukowski

Book ID
110235334
Publisher
Springer US
Year
2000
Tongue
English
Weight
71 KB
Volume
18
Category
Article
ISSN
0167-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of echinomycin in advance
Phase II trial of echinomycin in advanced soft tissue sarcomas
✍ Sarah A. Taylor; Barbara Metch; Stanley P. Balcerzak; Karl H. Hanson 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 232 KB

Thirty-four patients with advanced soft tissue sarcomas were entered in a phase II trial of echinomycin. Patients received 1.2 mg/m 2 intravenously (i.v.) weekly times four followed by a two week rest period. There were no objective responses. Dose limiting toxicity was gastrointestinal. Echinomycin